dimanche 15 novembre 2026
RechercherExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each, so you can check any claim. How we source
Source document· December 3, 2025

United States Business Intelligence Software Market Analysis 2025-2033 by Technology, Deployment, Enterprise, End User, States and Competitive Landscape

View original at globenewswire.com
United States Business Intelligence Software Market Analysis 2025-2033 by Technology, Deployment, Enterprise, End User, States and Competitive Landscape Dublin, Dec…
Opening lines of the source · short snapshot: read the full document at the original

Ce que nous avons tiré de cette source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • The drivers of BI market growth are rising data-driven decision-making, improving analytics, and growing demands for data visualization and reporting tools from companies across industries

    80% confidence
  • Qlik is on a mission to enable today's businesses to turn trust data into something actionable, access it, analyze it and act on it

    80% confidence
  • The U.S. BI software market will demonstrate a Compound Annual Growth Rate of 10.33% during 2025 to 2033

    80% confidence
  • Data security is a major issue in BI software adoption, especially for industries like healthcare, banking, and government dealing with sensitive data

    80% confidence
  • Cloud BI has the potential to lead the U.S. BI market in the future years due to increasing popularity of subscription-based models and superior security protocols

    80% confidence
  • High implementation and maintenance costs remain a challenge in the U.S. BI market, particularly for small and mid-size businesses

    80% confidence
  • The United States Business Intelligence Software Market is expected to grow from US$ 11.35 Billion in 2024 to US$ 27.49 Billion by 2033

    80% confidence
  • More than 80% of companies will move to the cloud as of 2024

    80% confidence
Ce que nous savons · l'intelligence derrière cette page
En direct du substrat
Ce que nous observons
Q4 2026 Biotech Catalyst Cluster: Late-Stage Data and PDUFA Dates Converge
Early-to-mid November 2026 is a dense run of clinical readouts and Q3 earnings at AHA, AASLD, ACR and ASH. Mid-cap biotechs (Vir, Mineralys, Arrowhead, Oryzon, Novartis, J&J) are reporting data that feeds into regulatory decisions. The next ones are the ivonescimab BLA (Nov 14) and the lorundrostat PDUFA (Dec 22), followed by ECLIPSE 2/3 and Maritime-1 readouts in Q1 2027. The list also includes an unrelated delisting track (EGM Nov 19, application Jan 25, 2027), and the facts have no AI or fintech content.
Notre lecture des données ›
Signaux que nous suivons
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Tendances que nous surveillons ›
Là où les sources divergent
Sources réconciliées : aucun conflit ouvert pour l'instant.
Nous signalons les conflits ouvertement ›
Vérifié récemment
✓ Vérifié avec la source d'origine
4,959
faits reliés à leur source, et nous signalons ceux qui ne tiennent pas.
101 entités suivies4,959 faits vérifiés avec la source5,585 documents sources archivés
Interrogez ces données → isubstrate.com